PATENT CLAIM ANALYSIS

Application Number: 16153249
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "345000"]

Abstract:
Compounds and pharmaceutically acceptable salts thereof that may be used to treat a disease, for example, Duchenne muscular dystrophy, AIDS, and progeria. The compounds and pharmaceutically acceptable salts thereof may be part of a pharmaceutical composition including a pharmaceutically acceptable support.

Claim (Index 2):
A pharmaceutical composition, comprising at least one compound of  claim 1  and a pharmaceutically acceptable support.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.51613
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14070799', '14958602', '12811931', '13388952', '13819120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7691492727085415
- 35 USC 102 Novelty (BERT): 0.5092846209969585
- Combined Prediction Score: 0.7431628075373832
- Mean Citation Score: 260.93586600000003
- Max Citation Score: 318.26913
- Similarity Product: 310.31908689021714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test